+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Albumin Market Research Report by Type, by Source, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4905056
  • Report
  • July 2021
  • Region: Global
  • 192 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Albumin Market will Grow to USD 15,329.13 Million by 2026, at a CAGR of 10.56%

FEATURED COMPANIES

  • Amgen
  • Baxalta Incorporated
  • Baxter International Inc.
  • Biotest AG
  • Celgene
  • CSL Behring LLC
The Global Albumin Market size was estimated at USD 8,390.41 Million in 2020 and expected to reach USD 9,248.56 Million in 2021, at a Compound Annual Growth Rate (CAGR) 10.56% to reach USD 15,329.13 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Albumin to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the Albumin Market was studied across Bovine Serum Albumin, Human Serum Albumin, and Recombinant Albumin.
  • Based on Application, the Albumin Market was studied across Culture Media, Drug Delivery, Therapeutic, and Vaccine Ingredient.
  • Based on Source, the Albumin Market was studied across Animal Sources and Plant Sources.
  • Based on End User, the Albumin Market was studied across Pharmaceutical & Biotechnology and Research Institutes.
  • Based on Region, the Albumin Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Albumin Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Albumin Market, including Amgen, Baxalta Incorporated, Baxter International Inc., Biotest AG, Celgene, China Biologic Products, Inc., CSL Behring LLC, Grifols SA, Mitsubishi Tanabe Pharma, Novozymes A/S, Octapharma AG, and Sigma-Aldrich Co..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Albumin Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Albumin Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Albumin Market?
4. What is the competitive strategic window for opportunities in the Global Albumin Market?
5. What are the technology trends and regulatory frameworks in the Global Albumin Market?
6. What is the market share of the leading vendors in the Global Albumin Market?
7. What modes and strategic moves are considered suitable for entering the Global Albumin Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen
  • Baxalta Incorporated
  • Baxter International Inc.
  • Biotest AG
  • Celgene
  • CSL Behring LLC
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Application Outlook
3.5. Source Outlook
3.6. End User Outlook
3.7. Region Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising utilization of albumin products in non-therapeutic segment
5.1.1.2. Growing number of chronic diseases such as cardiac surgery and infections
5.1.1.3. Awareness of recombinant albumin in vaccine formulations is increasing the demand
5.1.2. Restraints
5.1.2.1. Chances of post-operative risks in patients
5.1.3. Opportunities
5.1.3.1. Emerging research for the development of cost-efficient therapeutics
5.1.3.2. Development of methods for large-scale production of albumin
5.1.4. Challenges
5.1.4.1. Strict government regulations in the approval of albumin-based products
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Albumin Market, by Type
6.1. Introduction
6.2. Bovine Serum Albumin
6.3. Human Serum Albumin
6.4. Recombinant Albumin

7. Albumin Market, by Application
7.1. Introduction
7.2. Culture Media
7.3. Drug Delivery
7.4. Therapeutic
7.5. Vaccine Ingredient

8. Albumin Market, by Source
8.1. Introduction
8.2. Animal Sources
8.3. Plant Sources

9. Albumin Market, by End User
9.1. Introduction
9.2. Pharmaceutical & Biotechnology
9.3. Research Institutes

10. Americas Albumin Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Albumin Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Thailand

12. Europe, Middle East & Africa Albumin Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Amgen
14.2. Baxalta Incorporated
14.3. Baxter International Inc.
14.4. Biotest AG
14.5. Celgene
14.6. China Biologic Products, Inc.
14.7. CSL Behring LLC
14.8. Grifols SA
14.9. Mitsubishi Tanabe Pharma
14.10. Novozymes A/S
14.11. Octapharma AG
14.12. Sigma-Aldrich Co.

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL ALBUMIN MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 3. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 4. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2020 (USD MILLION)
FIGURE 5. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 6. GLOBAL ALBUMIN MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 7. GLOBAL ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL ALBUMIN MARKET: MARKET DYNAMICS
FIGURE 9. GLOBAL ALBUMIN MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 10. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 11. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2026
FIGURE 13. GLOBAL ALBUMIN MARKET SIZE, BY BOVINE SERUM ALBUMIN, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL ALBUMIN MARKET SIZE, BY BOVINE SERUM ALBUMIN, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL ALBUMIN MARKET SIZE, BY HUMAN SERUM ALBUMIN, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL ALBUMIN MARKET SIZE, BY HUMAN SERUM ALBUMIN, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL ALBUMIN MARKET SIZE, BY RECOMBINANT ALBUMIN, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL ALBUMIN MARKET SIZE, BY RECOMBINANT ALBUMIN, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 20. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2026
FIGURE 22. GLOBAL ALBUMIN MARKET SIZE, BY CULTURE MEDIA, 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL ALBUMIN MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 24. GLOBAL ALBUMIN MARKET SIZE, BY DRUG DELIVERY, 2018-2026 (USD MILLION)
FIGURE 25. GLOBAL ALBUMIN MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 26. GLOBAL ALBUMIN MARKET SIZE, BY THERAPEUTIC, 2018-2026 (USD MILLION)
FIGURE 27. GLOBAL ALBUMIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 28. GLOBAL ALBUMIN MARKET SIZE, BY VACCINE INGREDIENT, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL ALBUMIN MARKET SIZE, BY VACCINE INGREDIENT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2020 VS 2026 (%)
FIGURE 31. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2020 VS 2026 (USD MILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2026
FIGURE 33. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2026 (USD MILLION)
FIGURE 34. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 35. GLOBAL ALBUMIN MARKET SIZE, BY PLANT SOURCES, 2018-2026 (USD MILLION)
FIGURE 36. GLOBAL ALBUMIN MARKET SIZE, BY PLANT SOURCES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 37. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 38. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2026
FIGURE 40. GLOBAL ALBUMIN MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2026 (USD MILLION)
FIGURE 41. GLOBAL ALBUMIN MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 42. GLOBAL ALBUMIN MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 43. GLOBAL ALBUMIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 44. AMERICAS ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. ARGENTINA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. BRAZIL ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. CANADA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. MEXICO ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. UNITED STATES ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. ASIA-PACIFIC ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. AUSTRALIA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. CHINA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. INDIA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. INDONESIA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. JAPAN ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. MALAYSIA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. PHILIPPINES ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. SINGAPORE ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. SOUTH KOREA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. THAILAND ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. FRANCE ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. GERMANY ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. ITALY ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. NETHERLANDS ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. QATAR ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. RUSSIA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. SAUDI ARABIA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. SOUTH AFRICA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. SPAIN ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. UNITED ARAB EMIRATES ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. UNITED KINGDOM ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. GLOBAL ALBUMIN MARKET: FPNV POSITIONING MATRIX
FIGURE 74. GLOBAL ALBUMIN MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 75. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ALBUMIN MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL ALBUMIN MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL ALBUMIN MARKET SIZE, BY BOVINE SERUM ALBUMIN, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL ALBUMIN MARKET SIZE, BY HUMAN SERUM ALBUMIN, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL ALBUMIN MARKET SIZE, BY RECOMBINANT ALBUMIN, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL ALBUMIN MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL ALBUMIN MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL ALBUMIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL ALBUMIN MARKET SIZE, BY VACCINE INGREDIENT, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL ALBUMIN MARKET SIZE, BY PLANT SOURCES, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL ALBUMIN MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL ALBUMIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. AMERICAS ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. ARGENTINA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. BRAZIL ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. CANADA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. MEXICO ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. UNITED STATES ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. ASIA-PACIFIC ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. AUSTRALIA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. CHINA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. INDIA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. INDONESIA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. JAPAN ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. MALAYSIA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. PHILIPPINES ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. SINGAPORE ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. SOUTH KOREA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. THAILAND ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. FRANCE ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. GERMANY ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. ITALY ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. NETHERLANDS ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. QATAR ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. RUSSIA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. SAUDI ARABIA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. SOUTH AFRICA ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. SPAIN ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. UNITED ARAB EMIRATES ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. UNITED KINGDOM ALBUMIN MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. GLOBAL ALBUMIN MARKET: SCORES
TABLE 49. GLOBAL ALBUMIN MARKET: BUSINESS STRATEGY
TABLE 50. GLOBAL ALBUMIN MARKET: PRODUCT SATISFACTION
TABLE 51. GLOBAL ALBUMIN MARKET: RANKING
TABLE 52. GLOBAL ALBUMIN MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 53. GLOBAL ALBUMIN MARKET: MERGER & ACQUISITION
TABLE 54. GLOBAL ALBUMIN MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 55. GLOBAL ALBUMIN MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 56. GLOBAL ALBUMIN MARKET: INVESTMENT & FUNDING
TABLE 57. GLOBAL ALBUMIN MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 58. GLOBAL ALBUMIN MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Amgen
  • Baxalta Incorporated
  • Baxter International Inc.
  • Biotest AG
  • Celgene
  • China Biologic Products, Inc.
  • CSL Behring LLC
  • Grifols SA
  • Mitsubishi Tanabe Pharma
  • Novozymes A/S
  • Octapharma AG
  • Sigma-Aldrich Co.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll